Management of Most Common Toxicities Seen with Checkpoint Inhibitors

Management of Most Common Toxicities Seen with Checkpoint Inhibitors

Overview

NA

Target Audience

NA

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Mildred Flores, PhD

Date of Release

May 14th, 2025